Literature DB >> 25947333

Glomerular hyperfiltration in hypogonadotropic hypogonadic patients: Overlooking a cache?

Kerem Han Gözükara1, Abdulmuttalip Arslan, Sadık Görür, Mehmet Murat Rifaioğlu, Ayşe Çarlıoğlu.   

Abstract

PURPOSE: To investigate renal function in idiopathic hypogonadotropic hypogonadic (IHH) patients by measuring glomerular filtration rate (GFR) using modification of diet in renal disease formula, and determine whether there is any relationship between GFR and testosterone levels.
METHODS: Thirty-three patients with IHH and 37 healthy control subjects participated in this study.
RESULTS: The IHH group showed statistically significant higher GFR and proteinuria with respect to the control group (163.1 ± 46.9 to 117.9 ± 30.5 mL/min, p < 0.001; 0.2 ± 0.1 to 0.08 ± 0.02 mg/dL, p = 0.041, respectively). Uric acid and creatinine levels were statistically lower than in the control group (4.6 ± 0.5-3.6 ± 0.9 mg/dL, p = 0.02; 0.7 ± 0.2 to 0.9 ± 0.2 mg/dL, p < 0.001, respectively). Hyperfiltration positively correlated with IHH in multivariate linear regression analyses (β = 0.591, p < 0.001). In addition, in the IHH group, we found that the GFR increased independently of body mass index and age.
CONCLUSION: Our study confirms that low testosterone in IHH patients is associated with glomerular hyperfiltration. Patients with IHH should be carefully monitored with respect to their GFR.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25947333     DOI: 10.1007/s11255-015-0995-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  30 in total

1.  Hypertrophy and hyperfunction of the diabetic kidney.

Authors:  T H Hostetter
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  The glomerular endothelium: new insights on function and structure.

Authors:  Börje Haraldsson; Jenny Nyström
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

3.  Estimating glomerular filtration rate.

Authors:  W Greg Miller
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

4.  Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone.

Authors:  M Phillip; J E Arbelle; Y Segev; R Parvari
Journal:  N Engl J Med       Date:  1998-06-11       Impact factor: 91.245

5.  Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo.

Authors:  Michael P Hutchens; Tetsuhiro Fujiyoshi; Radko Komers; Paco S Herson; Sharon Anderson
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-23

6.  Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.

Authors:  Milena Braga-Basaria; Adrian S Dobs; Denis C Muller; Michael A Carducci; Majnu John; Josephine Egan; Shehzad Basaria
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

7.  Hypogonadism in a patient with a mutation in the luteinizing hormone beta-subunit gene.

Authors:  Hernán Valdes-Socin; Roberto Salvi; Adrian F Daly; Rolf C Gaillard; Pascale Quatresooz; Pierre-Marie Tebeu; François P Pralong; Albert Beckers
Journal:  N Engl J Med       Date:  2004-12-16       Impact factor: 91.245

8.  The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred.

Authors:  N de Roux; J Young; S Brailly-Tabard; M Misrahi; E Milgrom; G Schaison
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

Review 9.  Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth.

Authors:  Shehzad Basaria
Journal:  J Androl       Date:  2008-06-20

Review 10.  Hypogonadotropic hypogonadism revisited.

Authors:  Renato Fraietta; Daniel Suslik Zylberstejn; Sandro C Esteves
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more
  1 in total

1.  Influence of androgen deprivation therapy on serum urate levels in patients with prostate cancer: A retrospective observational study.

Authors:  Jun Won Park; Jae Hyun Lee; Hyon Joung Cho; You-Jung Ha; Eun Ha Kang; Kichul Shin; Seok-Soo Byun; Eun Young Lee; Yeong Wook Song; Yun Jong Lee
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.